TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients
Sign Up to like & getrecommendations! Published in 2022 at "Medicine and Pharmacy Reports"
DOI: 10.15386/mpr-2187
Abstract: Loss of pancreatic β–cell is a critical factor in the pathogenesis of type 1 diabetes and it also occurs in type 2. TXNIP (thioredoxin – interacting protein), also known as vitamin D3-upregulated protein 1, or… read more here.
Keywords: txnip; inhibition treatment; expression; txnip inhibition ... See more keywords